Bilateral Sacrospinous Colposuspension (BSC) in the Female Genital Prolapse With Urinary Urge Symptomatology
Study Details
Study Description
Brief Summary
Prospective non-randomised trial investigating the effect of vaginal vault Suspension on urge symptomatology in female patients with pelvic organ prolapse
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
A multicenter multinational Trial is performed in 250 female patients with pelvic organ prolapse (POP) and symptoms of urinary urge incontinence.
Dependent on the presence or abscence of the uterus patients are treated with bilateral sacrospinous uterine or vaginal vault suspension (BSC) by means of a tape specifically designed for this purpose.
Study Design
Outcome Measures
Primary Outcome Measures
- Influence of BSC placement on symptoms of urinary urge expressed by change in clinical examination [Checked after 6 weeks, six months and twelve months]
The change in symptoms after the surgical intervention is evaluated by clinical examination . The clinical examination is descriptive, not quantitative and no units are applicable or reportable.
- Change in score of standardized ICIQ documentation [Checked after 6 weeks, six months and twelve months]
The International Consultation on Incontinence Questionnaire is used to evaluate Change in Quality of life and urge symptomatology
Secondary Outcome Measures
- Anatomical correction of female pelvic organ prolapse [Checked after 6 weeks, six months and twelve months]
Clinical examination of pelvic floor anatomy
Eligibility Criteria
Criteria
Inclusion Criteria:
-
urge urinary incontinence or symptoms thereof
-
18 years old or older
-
Compliance regarding data collection, therapy and follow-up
-
written informed consent
-
simultaneous performance of surgical colporrhaphy permitted
Exclusion Criteria:
-
pelvic organ prolapse without symptoms of urinary urge
-
age less than 18 years
-
no informed consent
-
lack of compliance
-
adverse reaction to polypropylene
-
life expectancy less than anticipated duration of protocol
-
ASA 4
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Helios Medical Center | Schleswig | Germany | 24837 |
Sponsors and Collaborators
- Helios Medical Center Schleswig
Investigators
- Principal Investigator: Dirk G Kieback, MD,Ph.D, Helios Medical Center Schleswig
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HCR051631